Company BrightPath Biotherapeutics Co., Ltd.
Equities
4594
JP3274140007
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
59 JPY | 0.00% | +5.36% | -32.18% |
Business Summary
Number of employees: 42
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other
94.7
%
| 15 | 97.4 % | 5 | 94.7 % | -66.67% |
Research and Development
5.3
%
| 0 | 2.6 % | 0 | 5.3 % | -31.37% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 15 | 100.0 % | 5 | 100.0 % | -65.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 31/12/08 |
Director/Board Member | 55 | 30/04/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 31/05/15 | |
Akira Yamada
BRD | Director/Board Member | 67 | 30/04/03 |
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 31/12/08 |
Director/Board Member | 55 | 30/04/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 70,741,300 | 67,569,399 ( 95.52 %) | 1 ( 0.000001 %) | 95.52 % |
Company contact information
BrightPath Biotherapeutics Co., Ltd.
Life Innovation Center, 412 3-25-22 Tono-machi
210-0821, Kanagawa
+
http://www.brightpathbio.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-32.18% | 26.51M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 4594 Stock
- Company BrightPath Biotherapeutics Co., Ltd.